Palindromic rheumatism: From pathogenesis to clinical presentation — An updated review

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 45

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RHRE-10-4_006

تاریخ نمایه سازی: 11 آبان 1404

چکیده مقاله:

Palindromic rheumatism (PR) is referred to as recurrent and transient attacks of arthritis/periarthritis that last from a few hours to a few days and resolve spontaneously. The duration of attacks varies from ۲ hours to ۲ weeks, but they last an average of two days. During attacks, fever and other systemic symptoms are rare, and the patient is asymptomatic between attacks. It has been reported that ۲.۵% of people with musculoskeletal complaints had PR. Although the pathogenesis of PR is not precisely known, there is a large body of evidence that strongly suggests a role for immune dysregulation, genetic predisposition and environmental factors. Due to evidence of immunological imbalance in the PR, many authors consider PR to fall within the spectrum of autoimmune diseases. This view is supported by the close association with rheumatoid arthritis (RA) especially the presence of RA-related autoantibodies in the majority of PR patients, the predilection for the involvement of small joints of hand in PR and the high rate of progression to RA among these patients, and increased frequency of HLA-DR related shared epitope in PR. Autoantibodies related to RA, including rheumatoid factor and anti-citrullinated peptide antibodies, are commonly seen in patients with PR. However, a possible role of autoinflammation has been suggested in view of the relapsing/ remitting course of PR that resemble those observed in autoinflammatory disease, such as familial Mediterranean fever. MEFV mutations have been observed in ۱۲% of PR patients.

نویسندگان

Alireza Khabbazi

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences

Azam Safary

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cabrera-Villalba S, Sanmartí R. Palindromic rheumatism: a reappraisal. Int J ...
  • Hench P. Palindromic rheumatism. Arch IntMed ۱۹۴۴; ۷۳(۴):۲۹۳-۳ ...
  • Ansell BM, Bywaters EGL. Palindromicrheumatism. Ann rheum Dis. ۱۹۵۹; ۱۸:۳۳۱ ...
  • Mattingly S, Jones DW, Robinson WM,Williams RA, Dunn EC. Palindromicrheumatism. ...
  • Pasero G, Barbieri P. Palindromic rheumatism:you just have to think ...
  • Gonzalez-Lopez L, Gamez-Nava JI, JhangriGS, Ramos-Remus C, Russell AS, Suarez-Almazor ...
  • Powell A, Davis P, Jones N, Russell AS.Palindromic rheumatism is ...
  • Davatchi F, Jamshidi AR, Banihashemi AT,Gholami J, Forouzanfar MH, Akhlaghi ...
  • Kolahi S, Khabbazi A, Malek Mahdavi A,Ghasembaglou A, Ghasembaglou A, ...
  • Eliakim A, Neumann L, Horowitz J, Buskila D,Kleiner-Baumgarten A, Sukenik ...
  • Javidi-Aghdam K, Akbarzadeh-Khiavi M,Parvizpour S, Rahmani S, Sheikhmonazzah F,Khodaparast A, ...
  • IL-۱۷/IL-۲۳ cytokine profiles in palindromicrheumatism: Potential therapeutic targets andprognostic biomarkers ...
  • Pines A, Kaplinsky N, Orgad S, Gazit E, FranklO.Familial palindromic ...
  • Fisher LR, Kirk A, Awad J, Festenstein H,Alonso A, Perry ...
  • Barbieri P, Ciompi ML, Menicucci A, Pasero G.HLA antigens in ...
  • Gran JT, Husby G, Thorsby E. HLA antigens inpalindromic rheumatism, ...
  • Maksymowych WP, Suarez-Almazor ME,Buenviaje H, Cooper BL, Degeus C, ThompsonM, ...
  • Tamai M, Kawakami A, Iwamoto N, Arima K,Aoyagi K, Eguchi ...
  • Ben-Chetrit E Ben-Chetrit E. Palindromicrheumatism following COVID-۱۹ infectionevolved to rheumatoid ...
  • Verwilghen J, Panayi GS. Influence ofpregnancy on disease activity in ...
  • Russell AS, Devani A, Maksymowych WP. Therole of anti-cyclic citrullinated ...
  • Cabrera-Villalba S, Ramirez J, Salvador G,Ruiz-Esquide V, Hernández MV, Inciarte-Mundo ...
  • نمایش کامل مراجع